Tilray Brands Inc
For the period ended Nov 30, 2024. Filed Jan 10, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Nov 30, 2024 · Filed Jan 10, 2025
TLRY$2.65-7.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders' Equity (Unaudited)
Consolidated Statements of Stockholders’** Equity**
(in thousands of United States dollars, except for share data, unaudited)
| Accumulated | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Number of · Number of · Additional · other · Non- | |||||||||
| common · Common · treasury · Treasury · paid-in · comprehensive · Accumulated · controlling | |||||||||
| shares | stock | shares | stock | capital | loss | Deficit | interests | Total | |
| Balance at May 31, 2023 | 656,655,455 | $66 | — | $— | $5,777,743 | $(46,610) | $(2,415,507) | $14,251 | $3,329,943 |
| Share issuance - HEXO acquisition | 39,705,962 | 4 | — | — | 65,158 | — | — | — | 65,162 |
| Share issuance - settlement of contractual change of control severance incurred from HEXO acquisition | 865,426 | — | — | — | 1,500 | — | — | — | 1,500 |
| Share issuance - Double Diamond Holdings dividend settlement | 5,004,735 | — | — | — | 8,146 | — | — | — | 8,146 |
| Share issuance - HTI convertible note | 17,148,541 | 2 | — | — | 49,998 | — | — | — | 50,000 |
| Share issuance - RSUs exercised | 3,912,481 | — | — | — | — | — | — | — | — |
| Shares effectively repurchased for employee withholding tax | — | — | — | — | (4,860) | — | — | — | (4,860) |
| Equity component related to issuance of convertible debt, net of issuance costs | — | — | — | — | 3,953 | — | — | — | 3,953 |
| Stock-based compensation | — | — | — | — | 8,257 | — | — | — | 8,257 |
| Dividends declared to non-controlling interests | — | — | — | — | — | — | (7,891) | (7,891) | |
| Comprehensive income (loss) for the period | — | — | — | — | — | 3,049 | (71,525) | 15,822 | (52,654) |
| Balance at August 31, 2023 | 723,292,600 | 72 | — | — | 5,909,895 | (43,561) | (2,487,032) | 22,182 | 3,401,556 |
| Share issuance - HTI convertible note | 1,032,616 | — | — | — | 2,313 | — | — | — | 2,313 |
| Share issuance - Settlement of litigation claims from MediPharm Labs Inc | 1,573,152 | — | — | — | 3,477 | — | — | — | 3,477 |
| Share issuance - Repurchase of TLRY 23 convertible note | 7,000,000 | 1 | — | — | 20,457 | — | — | — | 20,458 |
| Share issuance - Settlement of equity component of TLRY 23 convertible note | — | — | — | — | (1,672) | — | — | — | (1,672) |
| Share issuance - RSUs exercised | 9,184 | — | — | — | — | — | — | — | — |
| Stock-based compensation | — | — | — | — | 8,201 | — | — | — | 8,201 |
| Comprehensive income (loss) for the period | — | — | — | — | — | 5,194 | (49,008) | 2,834 | (40,980) |
| Balance at November 30, 2023 | 732,907,552 | 73 | — | — | 5,942,671 | (38,367) | (2,536,040) | 25,016 | 3,393,353 |
| Balance at May 31, 2024 | 831,925,373 | 83 | — | — | 6,146,810 | (43,499) | (2,660,488) | 272 | 3,443,178 |
| Share issuance - At-the-Market (“ATM”) program | 36,693,307 | 4 | — | — | 66,468 | — | — | — | 66,472 |
| Share issuance - RSUs exercised | 6,823,140 | 1 | — | — | (1) | — | — | — | — |
| Share issuance - options exercised | 3,008 | — | — | — | — | — | — | — | — |
| Shares effectively repurchased for employee withholding tax | — | — | — | — | (2,661) | — | — | — | (2,661) |
| Stock-based compensation | — | — | — | — | 6,917 | — | — | — | 6,917 |
| Comprehensive income (loss) for the period | — | — | — | — | — | 3,622 | (39,165) | 5,051 | (30,492) |
| Balance at August 31, 2024 | 875,444,828 | 88 | — | — | 6,217,533 | $(39,877) | $(2,699,653) | $5,323 | $3,483,414 |
| Share issuance - At-the-Market (“ATM”) program | 30,517,557 | 3 | — | — | 45,041 | — | — | — | 45,044 |
| Share issuance - Repurchase of TLRY 27 convertible note | 10,034,635 | 1 | (3,682,609) | — | 17,084 | — | — | — | 17,085 |
| Share issuance - Settlement of equity component of TLRY 27 convertible note | — | — | — | — | (4,931) | — | — | — | (4,931) |
| Share issuance - Double Diamond Holdings dividend settlement | 13,217,588 | 1 | — | — | 23,823 | — | — | (23,824) | — |
| Share issuance - RSUs exercised | 35,983 | — | — | — | — | — | — | — | — |
| Share issuance - options exercised | 7,354 | — | — | — | — | — | — | — | — |
| Stock-based compensation | — | — | — | — | 7,237 | — | — | — | 7,237 |
| Comprehensive income (loss) for the period | — | — | — | — | — | (8,080) | (85,342) | (819) | (94,241) |
| Balance at November 30, 2024 | 929,257,945 | $93 | (3,682,609) | $— | $6,305,787 | $(47,957) | $(2,784,995) | $(19,320) | $3,453,608 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.